Posts by Lindsay Rutherford, Ph.D.

Lindsay is currently a Scientific Advisor at KCAS Bio, supporting Ligand Binding Assay (LBA) services. Lindsay has over 15 years of experience in assay development and previously worked at ICON overseeing the Large Molecule Method development team. Prior to her CRO work, Lindsay spent 10 years in the diagnostic and drug development space. She received her Ph.D. in Chemistry at the University of Arkansas and works out of the Kansas City area.

PATTERN_BLUE_1320x780_3 Blogs
Read article Overcoming Bioanalytical Method Transfer Challenges
Overcoming Bioanalytical Method Transfer Challenges

KCAS is a rapidly growing industry leader that continues to increase its vast knowledge surrounding assay transfers not only internally but externally as well.  As KCAS expands as a global leader in the bioanalytical space we have taken our knowledge surrounding internal assay transfers and extended that knowledge to external…

KCAS-blog-thumb_2023-07B_PK-ADCs Blogs
Read article Recent FDA Guidance for Pharmacokinetics and Antibody Drug Conjugates, and What They Mean for Your Projects at KCAS
Recent FDA Guidance for Pharmacokinetics and Antibody Drug Conjugates, and What They Mean for Your Projects at KCAS

With recent guidance released from the FDA, there are changes for PKs (Pharmacokinetics) and ADCs (Antibody Drug Conjugates) that must be clearly understood before making decisions for your drug product testing. ADCs combine the target specificity of monoclonal antibodies with the…